Overview
Mesangial cells are intrinsic components of the renal glomerulus, situated between capillary loops in the mesangium. These specialized cells exhibit characteristics of both smooth muscle cells and pericytes, enabling them to perform mechanical and regulatory functions. First identified in the 1960s, they are now recognized as central players in glomerular hemodynamics and pathological processes like diabetic nephropathy. Unlike other renal cells, mesangial cells possess unique contractile properties that allow them to modulate glomerular filtration surface area. They also produce extracellular matrix components and interact with endothelial cells to maintain glomerular architecture. Their dual role in structural support and immune modulation makes them critical subjects in nephrology research.
Key Features
Three defining characteristics distinguish mesangial cells: contractility, matrix synthesis capacity, and phagocytic activity. Their actin-myosin filaments enable contraction in response to vasoactive substances like angiotensin II, directly influencing filtration rate. This contractile response is clinically significant in hypertension management. These cells actively secrete collagen IV, fibronectin, and proteoglycans that form the glomerular basement membrane. Their matrix remodeling capabilities become pathological in conditions like glomerulosclerosis. Additionally, mesangial cells express Fc receptors and complement components, allowing them to clear immune complexes - a feature exploited in autoimmune kidney disease studies.
Application Areas
In pharmaceutical development, mesangial cell cultures serve as primary models for testing nephroprotective drugs. Their hyperproliferative response to growth factors mimics early diabetic nephropathy, making them ideal for anti-fibrotic compound screening. Over 60% of kidney disease research publications utilize these cells. Tissue engineering applications leverage mesangial cells' matrix-producing abilities for creating bioartificial glomeruli. Recent advances use them in organ-on-chip devices to simulate glomerular filtration barriers. Diagnostic manufacturers employ mesangial biomarkers like PDGF receptors in kidney injury test kits.
Precautions
Primary mesangial cells require careful handling due to rapid dedifferentiation in vitro. Laboratories should verify purity through positive staining for desmin and negative staining for cytokeratin before experiments. Cryopreserved batches typically maintain viability for 6-12 months at -150°C. Researchers must account for species-specific differences - murine cells proliferate faster than human counterparts but may not accurately model human disease. Contamination risks increase with prolonged culture beyond passage 8. Strict serum concentration controls (5-10% FBS) prevent undesirable phenotypic shifts.
B2B Procurement Guide
Reputable suppliers provide cells with documented passage history, doubling time data, and sterility certificates. For drug screening applications, request cells pre-characterized for relevant receptors (AT1, TGF-β). Bulk purchases (5+ vials) often attract 15-20% discounts from major distributors. Consider procurement timing carefully - primary human cells from tissue banks often have 2-3 week lead times. Some vendors offer pre-plated cells in culture-ready formats at 20-30% premium. Always validate new batches with control experiments comparing matrix production rates to existing stocks.
Related Manufacturers
- 主营：兔羊膜间质细胞、ELISA试剂盒、PCR试剂盒、科研试剂
- 主营：兔羊膜间质细胞说明书、ELISA试剂盒、PCR试剂盒、科研试剂
- 主营：嵌段共聚物、合成磷脂、荧光染料、NPs标记间充质干细胞、PEG、点击化学、量子点
- 主营：igg抗体、糖蛋白、试剂盒、兔羊膜间质细胞说明书、脂蛋白、人瘦素、粗纤维、猪睾酮、烯二酮、nad激酶、测试盒、牛瘦素、牛胆酸、原果胶、磷酸酶、犬肾素、含水量、人蛋白、甜菜碱、igm抗体、dna抗体、磷脂酶、大鼠超、犬叶酸、人胆酸、样受体